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Abstract
Background: Health disorders, due to the use of drugs with fiscalized substances, including controlled substances,
have become a common problem in Colombia. Multiple reasons can help explain this problem, including self-
medication, since access to these drugs may be easier. Also, there is a lack of knowledge that these drugs are safer
than illicit drugs. The use of these drugs without a valid medical prescription and follow-up can have negative
consequences such as drug abuse, addiction, and overdose, and eventually, have negative health consequences.
Pharmacy staff is essential to both assure the correct drug use and minimize prescription errors to help outpatients
have better management of their pharmacotherapy. For this reason, it is necessary to increase key competencies
like knowledge, skills, and attitudes in the pharmacy staff of ambulatory (outpatients) pharmacies.
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Methods: This study is a prospective, cluster-randomized, parallel-group, multicenter trial of drugstores and
drugstores/pharmacies (ambulatory pharmacies). The study is designed to determine the effectiveness of a drug
with fiscalized substance dispensation, health education, and pharmacovigilance continuing education program in
drugstores and drugstores/pharmacies. Pharmacy staff will be randomly selected and assigned to one of the study
groups (intervention or control). The intervention group will receive a continuing education program for over 12
months. The control group will receive only general information about the correct use of complex dosage forms.
The primary objective is to evaluate the effectiveness of a continuing education program to improve pharmacy
staff competencies (knowledge, skills, and attitudes) to improve the ambulatory (outpatient) pharmacy services:
dispensation, health education, and pharmacovigilance of drugs with fiscalized substances. The secondary
outcomes include (a) processes associated with the management of drugs with fiscalized substances in drugstores
and drugstores/pharmacies, including regulation compliance; (b) degree of implementation of ambulatory
(outpatient) pharmacy services targeting these drugs in drugstores and drugstores/pharmacies; (c) patient
satisfaction with such services; and (d) pharmacy staff satisfaction with the continuing education program.
Discussion: This clinical trial will establish whether providing a continuing education program for the adequate
utilization of drugs with fiscalized substances improves pharmacy staff competencies regarding these drugs.
Trial registration: ClinicalTrials.gov NCT03388567. Registered on 28 November 2017. First drugstore or drugstore/
pharmacy randomized on December 1, 2018.
Protocol version: 0017102017MC
Keywords: Dispensation, Health education, Pharmacovigilance, Drugstores, Pharmacies, Pharmacy staff, Fiscalized
substances, Controlled drugs
Background
Drugs with fiscalized substances, for example, benzodi-
azepines, tricyclic antidepressants, anxiolytics, antipsy-
chotics, opioid analgesics, among others, are essential in
various fields of medicine, such as pain treatment, ob-
stetric emergencies, and mental disorders such as the
treatment of drug dependence substances, psychiatry,
and neurology. These substances are regulated by inter-
national conventions on drug control, recognizing their
potential to be misused and cause harm, such as de-
pendency syndrome and health disorders [1]. Drugs with
fiscalized substances have a substantially high risk of
causing a substance use disorder [2]. As a result, disor-
ders due to drug abuse have become a common prob-
lem. Multiple reasons can help explain this problem,
including self-medication, because access to these drugs
may be more accessible. Besides, there is a lack of belief
that these drugs are safer compared to illicit drugs [2].
Furthermore, there are failures in the surveillance and
control of the processes; for instance, worldwide, it is
common that many non-over-the-counter medications,
including medications with controlled substances, are
dispensed without a valid medical prescription even
when it is mandatory [3].
Worldwide, there is evidence on the effectiveness and
relevance of pharmaceutical interventions in combin-
ation with Information and Communication Technolo-
gies (ICT), continuing education programs, and network
support between pharmacy staff and other health
professionals on the use of drugs with fiscalized sub-
stances [4–7]. Competent pharmacists with positive atti-
tudes, skills, and enough knowledge are crucial to the
outcome of pharmaceutical care for patients. Pharmacists
are required to improve the correct use of drugs, minimize
medication errors, and help outpatients have better man-
agement of their pharmacotherapy. However, it is neces-
sary to increase those competencies, especially in the
correct use of drugs with fiscalized substances, including
controlled drugs. These strategies are essential to improve
collaboration and, consequently, to achieve optimal medi-
cation management. In this regard, the impact of continu-
ing education in pharmacy staff has been described,
focusing efforts on promoting the proper use of drugs, in-
cluding opioids, antidepressants, and anxiolytics, and even
preventing the abuse of these medications [8–12].
In the Colombian context, it is possible to consider
the global concept of ambulatory (outpatient) pharma-
cies [13]. In this concept, it is possible to include (a) am-
bulatory (outpatient) pharmaceutical services (similar to
the international concept of community pharmacies)
which play a part in the care of patients affiliate to
health system and (b) drugstores and drugstores/phar-
macies, which may or may not play a part in the care of
patients affiliate to the health system. Therefore, the cor-
rect homologation to community pharmacies would be
ambulatory pharmaceutical services. However, the main
concern regarding the correct use of drugs with con-
trolled substances is found in the context of the
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drugstores and drugstores/pharmacies, and not in ambu-
latory pharmaceutical services.
Colombian drugstores and drugstores/pharmacies dis-
pense drugs, medical products, drugs based on natural
resources, cosmetics, and other products (e.g., toiletry
products). These pharmacies are private healthcare es-
tablishments, and unfortunately, some non-over-the-
counter medications are being dispensed without med-
ical prescription. For example, in the case of antibiotics,
a study found that 80.3% of the sales of antibiotics in
drugstores and drugstores/pharmacies of Bogota dis-
pensed without a valid medical prescription and so not
fulfilling the current established legal requirements.
Additionally, pharmacy staff is not sufficiently educated
to manage and process these drugs. These situations
contribute to the inappropriate use of antibiotics and are
factors that induce antimicrobial resistance [14].
In the Colombian context, the pharmacy staff is a person
who works within drugstores and drugstores/pharmacies
with any of the following levels of training (professional,
technological, or technical). Besides, there is the empirical
profile of the Drug Dealer (a name given to those who do
not have technical, technological, or professional training;
they are also called Director of Drugstores). Furthermore, in
the Colombian context, the pharmacy staff of drugstores and
drugstores/pharmacies are frequently the first healthcare pro-
viders with whom a patient comes into contact before using
a medication, principally because the ambulatory (outpatient)
pharmacies are accessible. It is common for patients not to
visit their doctors until their health problems worsen.
Further, some studies suggest that imposing an exces-
sive workload on pharmacy staff reduces the time that
they spend with each patient and leads to less control
over medical prescriptions [15]. The capacity to improve
therapeutic outcomes, patients’ quality of life, scientific
advancement, and enhancement of our public health im-
peratives is dependent on specific competencies of the
pharmacy staff [16]. For the World Health Organization
(WHO) and Pharmaceutical International Federation
(FIP), these competencies include knowledge, skills, and
attitudes, which are revealed when they perform either a
task or a job. Competencies could be achieved through
education, training, and experience [17].
To the best of our knowledge, there is no information
available from studies related to pharmacy staff compe-
tencies in the provision of outpatient pharmacy services:
dispensing, health education, and related pharmacovigi-
lance related to controlled substance drugs (including
controlled drugs). However, some studies have evaluated
the effect of educational interventions on the pharmacist
to improve knowledge and practices in health problems
in which the use of drugs with fiscalized substances is a
therapeutic alternative, such as depression, anxiety, and
substitution treatment of opioids [10, 18, 19].
Consequently, the implementation of a continuing
education program through the integration of different
methods and tools supported by ICT, such as a web-
based social networking site and a virtual classroom,
could favor access to relevant and quality information
on health promotion, disease prevention, and the proper
use of drugs with fiscalized substances (including con-
trolled drugs). They facilitated the improvement of the
labor competencies of the pharmacy staff, in addition to
improving the satisfaction of patients and caregivers
about the ambulatory (outpatient) pharmacy services of-
fered in drugstores and drugstores/pharmacies.
Objectives
The primary objective is to evaluate the effectiveness of a
continuing education program to improve pharmacy staff
competencies (knowledge, skills, and attitudes) to improve
the ambulatory (outpatient) pharmacy services: dispensa-
tion, health education, and pharmacovigilance of drugs
with fiscalized substances (including controlled drugs).
The secondary objective is to characterize the processes
associated with the utilization of drugs with fiscalized sub-
stances (including controlled drugs) and regulation com-
pliance and the degree of implementation of ambulatory
(outpatient) pharmacy services. The third objective is to
evaluate the satisfaction of patients and caregivers with
ambulatory (outpatient) pharmacy services. The fourth
objective is to evaluate the satisfaction level of pharmacy
staff with the provided educational program.
Trial design
A multicenter, prospective, parallel-group, cluster-
randomized controlled, superiority trial will be con-
ducted (see Figs. 1 and 2). The study will be carried out
over 12 months (1 year) of intervention (i.e., the continu-
ing education program) delivery and follow-up. Drug-
stores and drugstores/pharmacies (the clusters) will be
randomized at a 1:1 ratio to enroll in either the interven-
tion group or the control group. The geography zone
(neighborhoods) will be randomized stratified.
Methods
Study setting
The study will be conducted in drugstores and drugstores/
pharmacies of Antioquia (one of the 32 Colombian depart-
ments), including the central city, Medellin, and the Metro-
politan Area. Medellin is the capital of the department of
Antioquia and has over 3.5 million inhabitants in 10 munici-
palities (Metropolitan Area of Medellín) by 2015. According
to the projection by the United Nations, it is estimated that
4,389,585 people would inhabit the Metropolitan Area, 844,
882 more people between 2010 and 2030, at a rate of 1% per
year and with higher dynamics in the urban area [20].
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Additionally, the number of drugstores and drugstores/
pharmacies has been growing steadily. According to data
of the study of characterization of the pharmaceutical sec-
tor in Colombia by 2014, carried out by the National Col-
lege of Pharmaceutical Chemists of Colombia, which is
the central organization of the professional pharmaceut-
ical union in the country, there were more than 20,000
drugstores and drugstores/pharmacies [21].
Eligibility criteria
Inclusion criteria
Drugstores and drugstores/pharmacies From a list of
1500 drugstores and drugstores/pharmacies of Antio-
quia, we identified those that participated in a cross-
sectional epidemiological study on the use of drugs with
fiscalized substances carried out in 2016 [22]. Drugstores
and drugstores/pharmacies will be eligible for inclusion
in the study if they are registered with the delegated en-
tity for surveillance, which is located in Medellín and the
Metropolitan Area.
Pharmacy staff The study will recruit at least one phar-
macy staff member from each drugstore or drugstore/
pharmacy (professional, technological, technical, or Drug
Dealer). To be included in the study, the pharmacy staff
will have to meet the following criteria: (a) work in the
drugstores or drugstores/pharmacies and (b) have access
to a computer and the Internet.
Fig. 1 The continuing education program process and methodology
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Patients or caregivers The study will recruit at least
three patients or caregivers from drugstores or drug-
stores/pharmacies and will assess whether each patient
meets all the inclusion criteria. The inclusion criteria
will be the following: (a) patients or caregivers should be
at least 18 years old, (b) they must be at the drugstores
or drugstores/pharmacies at the time of being inter-
viewed by the researcher, and (c) dispensing at least one
drug with or without a medical prescription.
Exclusion criteria
Pharmacy staff and patients/caregivers that refuse to sign
the consent form are not included (it is necessary to ob-
tain the consent before any study-related procedures
were conducted).
Sample size
A study carried out in Spain evaluated the competences
pharmacists, principally the knowledge before and after
an educational intervention facilitated by pharmacists,
finding that the intervention increases in 37% the know-
ledge of the pharmacists who attended the course [23].
Therefore, the continuing education program is expected
to improve the pharmacy staff competencies in the inter-
vention group at least 30% and in the control group by
15% (less in improving or increasing competencies).
With a confidence level of 95% and a power of 80% and
superiority design, it was calculated that it is necessary
to include at least 121 drugstores or drugstores/pharma-
cies in each group. To cover losses to follow-up, the
sample was increased by 10%, increasing the sensitivity
for the fulfillment of secondary objectives; the size of the
final sample will be 135 drugstores or drugstores/phar-
macies for each group (1:1 ratio).
Recruitment
Drugstores or drugstores/pharmacies and pharmacy staff
We will invite the pharmacy staff of 700 drugstores and
drugstores/pharmacies to participate in the study. The
researchers will explain to the pharmacy staff the objec-
tives and the study design in meetings where they will
accept their participation. Besides, all drugstores and
drugstores/pharmacies will be visited by a pharmacist
(no researcher) to obtain their written consent, between
December 2018 and January 2019. The drugstores and
drugstores/pharmacies that do not attend the meetings
will be called by phone by a researcher to invite them to
the rehearsal, and then they will be visited. If neither
pharmacy staff of drugstores and drugstores/pharmacies
do not agree to participate in the trial, they will be
Fig. 2 Description of the registration calendar, interventions, and evaluations
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replaced by another from the same geographic area.
Pharmacy staff will not receive any economic compensa-
tion for participating in the study. The researchers will
ensure that the data collected is anonymous and strictly
confidential.
The inclusion and exclusion criteria of pharmacy staff
that accept to participate in the study will be evaluated.
Some of their demographic and academic characteristics
will be recorded: age, sex, highest educational level, year
of pharmacist title (if applicable), university or educa-
tional institution where degree was obtained (if applic-
able), function in the pharmacy (owner/worker), hours
worked per week, continuing education in recent years,
the intensity of continuing education, time of experience
as a pharmacy staff, and if they currently live in the same
neighborhood as the drugstores or drugstores/pharma-
cies where they are employed.
Patients or caregivers
At least three patients or caregivers from each drugstore
or drugstore/pharmacy will be recruited who had previ-
ously been dispensed with medication by the pharmacy
staff of each drugstore or drugstore/pharmacy. The re-
searchers will inform the potential candidates (patients
or caregivers) about the study and will ask for their
authorization to participate; they will be registered and
will sign a consent form. The variables related to the ob-
jectives of the study in the case of the patients who agree
to participate will be assessed. The patients will not re-
ceive any compensation for participating in the study.
One of the researchers will make visits to the phar-
macy staff. The visits will be organized according to the
geographical distribution where the drugstores and
drugstores/pharmacies are located. The researcher will
enter the drugstores or drugstores/pharmacies and re-
main there for as long as necessary to interview a mini-
mum of 3 patients or caregivers who enter the
drugstores or drugstores/pharmacies requesting the drug
dispensing process. Patients or caregivers will be selected
in order of arrival or admission to the drugstores or
drugstores/pharmacies. The researcher will approach the
patient or caregiver and invite them to participate in the
study. If the patient or caregiver agrees, they will sign
the informed consent, and they will be interviewed to
complete the measurement questionnaire. There will be
no selection criteria related to the characteristics of the
patient or caregiver, nor of the medications dispensed.
Allocation
Group allocation (the intervention group or the control
group) will be blinded and will be determined using a
computer-generated random number table and placed in
numbered, designed by a person external to the study
and otherwise unrelated to it using Microsoft Excel®
(version 2010, Microsoft ®).
Blinding
Blinding of pharmacy staff is not possible because of the
nature of the intervention. Patients and caregivers will
be able to be blinded because they will not receive given
details of the intervention.
Interventions
Intervention group
The continuing education program is made up of 3 dif-
ferent and independent actions that will be executed
transversely during the duration of their implementation
and follow-up (12 months). These actions will be applied
at different times, as described in Fig. 1. Next, we give
details of each of the actions.
Web-based social networking sites and access to a
virtual classroom The integration of pharmacy staff
into a web-based social networking site and access to a
virtual classroom can favor access to relevant and quality
information on health promotion, disease prevention,
and correct use of drugs. The access and interactivity in
the web-based social networking site will be continuous
24 h 7 days a week during the 12months that the inter-
vention lasts. Web-based social networking will be de-
signed and built according to current trends, to develop
a highly usable and accessible site based on the require-
ments and functionalities of an expert panel. Some of
the characteristics and functionalities of the web-based
social networking site will be as follows:
a. Pharmacy staff will access from personal computers
(PC) and mobile devices with a touch screen.
b. Pharmacy staff will be able to describe their status;
to establish communication with other pharmacy
staff, the administrators of the platform,
researchers, and invited experts; to establish their
geographical location; to create events; and to
upload images, videos, and links from other pages,
resources in the web, or social networking sites
such as YouTube, Facebook, Twitter, and
Instagram.
c. Pharmacy staff will comment on all materials
uploaded to the platform by different users
(pharmacy staff, researchers, or administrators of
the platform). Additionally, they will have access to
video tutorials, frequently asked questions (FAQ),
comments, forums, opinion polls, and downloadable
document libraries.
d. A gamification system must be introduced to
encourage its use with which all user actions (point
system). The gamification system will consist of a
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pharmaceutical marketing strategy to generate value
to the person who is participating in a course so
that they are motivated to develop and finish it. For
example, generate their content (images,
photographs, and videos). Also, they will be linked
with content from other social networking sites
such as YouTube, Facebook, Twitter, and Instagram
to interact with other users.
e. Pharmacy staff will be accessing a virtual classroom
of an update course for the proper utilization of
drugs with fiscalized substances.
Virtual course The virtual course will be composed of 7
modules. The study time for each module will require
an average of 20 h of study (ten synchronous hours and
ten asynchronous hours). Each module will be struc-
tured as follows: (a) initial evaluation,( b) development
of themes and content, and (c) final evaluation. The vir-
tual course will be designed using Moodle 3.3.2+, which
is a Learning Management System (LMS) for the devel-
opment, administration, and documentation of learning.
The virtual course will have a combination of different
multimedia tools such as audios (locutions), videos with
experts, animated videos, animations, videocasts, info-
graphics, and interactive tests with drag and drop exer-
cises, association, completion, and multiple selection
responses.
The development of the virtual course will not be car-
ried out in a synchronized manner among all subjects.
Therefore, the course will be carried out in a staggered
way; that is, the seven modules will be activated system-
atically 1 to 7, on average, every 45 to 60 days. These
modules constitute a refresher course in knowledge, and
those who complete all the modules of the virtual course
will be certified by the University of Antioquia. It will be
established as an actualization course.
For the development and construction of the virtual
course, a descriptive observational study was conducted
in 2016, seeking to characterize the needs and percep-
tions of information and continuing education to favor
the proper use of drugs with fiscalized substances [22].
The current Colombian regulations related to the com-
petencies necessary for work performance have been
reviewed (Colombian regulations focused on the classifi-
cation of labor competencies for the performance of am-
bulatory pharmaceutical services and drugstores and
drugstores/pharmacies). Subsequently, the topics and
contents were selected and supported with a review of
the literature to build the seven modules: (1) pharma-
ceutical terminology and basic pharmacology, (2)
pharmaceutical legislation, (3) technical and administra-
tive management of the pharmacy, (4) communication
and health education from the pharmacy, (5) good prac-
tices of dispensation and proper utilization of drugs, (6)
pharmacovigilance from the pharmacy, and (7) pharma-
ceutical actuation of some common diseases in the phar-
macy and in which drugs with fiscalized substances are
used (depression, anxiety, sleep disorders, and pain man-
agement). Finally, this information was socialized and
reviewed with a panel of experts. Table 1 describes the
objectives of the modules of the course for the proper
utilization of drugs with fiscalized substances.
Pharmacy staff training All pharmacy staff of the inter-
vention group will be invited to participate in three face-
to-face meetings as a complement to the virtual course
for the proper utilization of drugs with fiscalized sub-
stances. Each meeting will last 4 h, for a total of 12 h of
face-to-face training. Each pharmacist will make their
presentation according to the topics programmed in
each training meeting: (a) training 1, feedback from
modules 1 and 2 of the virtual course; (b) training 2,
feedback from modules 3, 4, and 5 of the virtual course;
and (c) training 3, feedback from modules 6 and 7 of the
virtual course. Lectures will be prepared in PowerPoint
presentations, videos, and practical activities such as
role-playing and case presentation. The pharmacists who
will conduct the face-to-face meetings are professional
pharmacists, with experience in teaching and research in
the specific topics and a strong background in clinical
and therapeutic pharmacy. The professional pharmacists
are also co-authoring the virtual course modules.
Control group
Due to the nature of the study, there will be no blinding
since the pharmacy staff of drugstores and drugstores/
pharmacies that meet the inclusion criteria will be in-
formed about the study and will register after their
signed authorization. Pharmacy staff in the control
group will receive written material on the correct use of
complex pharmaceutical forms, with information that fo-
cuses on the importance of providing this information to
patients and caregivers to achieve the goals of treatment.
Randomization will take place at baseline. The written
material will be delivered during the follow-up time.
Criteria for discontinuing
When pharmacy staff leave or change their place of
work to the original one where they were initially ran-
domized in the study or decide voluntarily to withdraw
from the study, it will be considered as a criterion for
discontinuing.
Strategies to improve adherence to intervention
protocols
The pharmacy staff in both groups will receive phone
calls from one of the researchers to encourage compli-
ance with the protocol. The pharmacy staff of the study
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will not be blinded to the assignment of the intervention,
and the same researcher will visit both groups. The re-
searcher will visit all drugstores and drugstores/pharmacies
to train and provide technical support to the pharmacy staff
of the intervention group in the access and use of the virtual
classroom and the virtual course. During the 12months that
the monitoring and intervention will last, one of the re-
searchers will be available to receive telephone calls to solve
doubts and academic concerns and provide technical support
related to the virtual classroom and the virtual course. Tele-
phone calls have several purposes: (1) accompany pharmacy
staff during the study and promote adherence to the con-
tinuing education program for their development, (2) accom-
paniment and technical support in the use of the educational
platform, and (3) promote communication to invite phar-
macy staff to face-to-face training sessions to be scheduled to
complement their training.
Outcomes
Pharmacy staff competencies (knowledge, skills, and atti-
tudes) will be assessed using two self-applied question-
naires. The measurements will be performed at baseline
(T0) before the intervention and 12months (1 year) after
completing the follow-up (T12). Additionally, the simu-
lated patient technique will be used to evaluate the skills
and attitudes of the pharmacy staff in the dispensation
and the information supply for the correct use of drugs
(T0 and T12).
Secondary outcomes
The following are the secondary outcomes of the study:
a. Characterization of the processes in the drugstores
and drugstores/pharmacies. The measurements will
Table 1 Objectives of the virtual course modules for the proper utilization of drugs with fiscalized substances
Module Objectives
Module 1. Pharmaceutical terminology and basic pharmacology 1. Identify the different concepts and terms associated with pharmacology
and pharmacotherapy.
2. Understand the concepts of the processes covered by pharmacokinetics
(release, absorption, distribution, metabolism, and excretion) and
pharmacodynamics (action and effect).
3. Know the different types of drug interactions and their implications on
the patient.
Module 2. Pharmaceutical legislation 1. Know the essential and practical concepts of legislation in Colombia.
2. Differentiate the standards corresponding to pharmaceutical products,
establishments, and pharmaceutical services.
3. Identify the different norms that regulate the use of controlled drugs
and drugs with fiscalized substances in Colombia.
Module 3. Technical and administrative management of the pharmacy 1. Recognize the appropriate mechanisms for the selection and purchase
of drugs and pharmaceutical products, contributing to the proper
management of inventories.
2. Identify strategies for the reception and storage of drugs and
pharmaceutical products under optimal conditions of temperature,
humidity, and cleanliness.
3. Know the recommendations for inventory management and
management.
Module 4. Communication and health education from the pharmacy 1. Know the strategies for communication and dissemination of
information on medications and health issues, as well as the tools and skills
to carry out health education activities to patients.
2. Identify some of the recommendations for carrying out communication
and health education activities for special populations (pediatrics,
pregnancy, and the elderly).
Module 5. Good practices of dispensation and proper utilization of
drugs
1. Know the necessary recommendations for the correct practice of
dispensation medications.
2. Relate the proper use of drugs, the aspects involved in said use, and the
responsibility of the pharmacy staff.
Module 6. Pharmacovigilance on the pharmacy 1. Learn the basic knowledge of pharmacovigilance, as well as the
strategies for causality analysis of adverse drug effects.
2. Know the recommendations to implement a pharmacovigilance
program from a pharmacy.
Module 7. Pharmaceutical actuation of some common diseases in the
pharmacy (depression, anxiety, sleep disorders, and pain management)
1. Identify recommendations and pharmacotherapeutic strategies for pain
management.
2. Differentiate recommendations and pharmacotherapeutic strategies for
the control of depression, anxiety, sleep disorders, and other mental
disorders.
3. Recognize the risks associated with improper use and abuse of drugs
with fiscalized substances.
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be performed only at baseline (T0) before the
intervention.
b. Implementation of the ambulatory (outpatient)
pharmacy services in the drugstores and drugstores/
pharmacies. The measurements will be performed
only at baseline (T0) before the intervention.
c. Level of pharmacy staff satisfaction with the
continuing education program. The measurements
will be performed only on the intervention group
pharmacy staff after completing the follow-up
(T12).
d. Level of satisfaction of patients or caregivers with
ambulatory (outpatient) pharmacy services. The
measurements will be performed at baseline (T0)
before the intervention and 12 months (1 year) after
completing the follow-up (T12)
Data collection
Data will be collected between December 2018 and De-
cember 2019, conducted over 12 months of intervention
delivery and follow-up. The data obtained in this study
will be registered in an electronic database. The effect-
iveness of the continuing education program will be
assessed before and after the intervention. The same
questionnaires will be used in T0 and T12 for the phar-
macy staff and the patients or caregivers. An additional
measurement will be made for the intervention group
12months after the end of the follow-up time in order
to evaluate the effects of the educational intervention
over time. All measuring instruments will be reviewed
and adjusted by a group of 10 experts. Three different
sessions will be carried out, in which the questionnaire
will be presented, and the experts will be asked for their
opinions regarding the relevance of the content of the
items (content validity).
Community pharmacy staff competencies (knowledge, skills,
and attitudes)
For the measurement of knowledge, a self-applied ques-
tionnaire of 50 multiple-choice questions (4 possible an-
swers) with only one answer was constructed, and it will
be categorized as correct or incorrect. The questionnaire
will have the following topics: (1) pharmaceutical ter-
minology and basic pharmacology, (2) pharmaceutical
legislation, (3) technical and administrative management
of the pharmacy, (4) communication and health educa-
tion from the pharmacy, (5) good practices of dispensing
and proper use of medicines, (6) pharmacovigilance
from the pharmacy, and (7) pharmaceutical intervention
on some common diseases in pharmacy (depression,
anxiety disorder, sleep disorders, and pain management).
For the measurement of skills and attitudes, a self-
applied questionnaire of 100 questions or performance
criteria was constructed, which will be evaluated
according to the frequency in which it will perform. For
this purpose, a Likert scale will be established with four
possible options: never (1), sometimes (2), usually (3), or
always (4) that evaluate the following competencies—(a)
provision of patient care: initial contact with the patient,
medical prescription, medication needs, medication rec-
onciliation, medication supply, use of guidelines and
protocols, drug specifications, drug interactions, infor-
mation about medications and patient education, add-
itional activities, identification of drug-related problems,
patient care, and evaluation of results; (b) personal: per-
sonal organization, practical communication skills, team-
work, and professionalism; (c) problem-solving: access
related to information, knowledge, information analysis,
and monitoring the patient; and (d) management and
organization: clinical management and pharmacological
safety, service provision, acquisition, and satisfaction of
the services offered.
For the construction of the questionnaire, a search of
reference documents, associations, and working groups in
this area was carried out at an international level, focused
on the guidelines and recommendations related to the
proper functioning of the ambulatory pharmaceutical ser-
vices and drugstores and drugstores/pharmacies. The
international reference documents of the International
Pharmaceutical Federation (FIP) and the World Health
Organization [16, 17, 24] were used as sources of review,
in which a minimum set of competencies was described
within the different frameworks of professional perform-
ance. Additionally, different labor competency frameworks
in different countries such as England, Ireland, and
Australia [25–27] and the regulations in Colombia associ-
ated with the labor competencies of the pharmacy staff
were reviewed. Additionally, a structured review was con-
ducted on the measurement and evaluation of labor com-
petencies, with the following MeSH terms: “Professional
Competence” OR “Health Knowledge, Attitudes, Practice”
AND “Pharmacists.” Finally, the results of the reviews
were considered. The adjustment and revision of the in-
strument were carried out with a group of experts from
the areas of healthcare pharmacy, research, and teaching.
In total, 993 bibliographic references were identified with
the search strategy, selecting nine articles that globally
assessed competencies in 4 countries: Croatia, Australia,
England, and Serbia [25–33].
Simulated patient technique
The simulated patient technique will be used to evaluate
the skills and attitudes of the pharmacy staff in the dis-
pensation and the information supply for the correct use
of drugs with fiscalized substances. The simulated pa-
tients will be trained to represent and act coherently and
accurately predetermined disease, specifically in pain
management. Before carrying out the visits, the
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simulated patients who were previously trained would
sign an informed consent in order to guarantee the con-
fidentiality of the information collected. The pharmacy
staff will not know at any time that the simulated patient
is not real. A questionnaire will be constructed which
will assess the following: (1) the drug dispensed, (2) the
use of tools to provide information, and (3) the informa-
tion provided on drug precautions and recommenda-
tions. The questionnaire will evaluate the minimum
information that the pharmacy staff should provide to
patients according to the indications, precautions, and
recommendations for the use of the drug and the disease
that will simulate (tramadol and lower back pain) [34,
35]. Both the information and the dispensing process
must be carried out under the regulatory requirements.
Characteristics of the event and simulated patient
Patient with an average age of 20 years will go to the
drugstores or drugstores/pharmacies with a medical for-
mula of tramadol 100 mg/ml bottle 10 ml drops (10
drops/8 h), prescribed by a doctor, for a week-long back
pain associated with physical exertion. There will be
training performed for simulated patients. Additionally,
a first dispensation will simulate (simulated patient will
use tramadol for the first time). To guarantee the quality
and validity of the data, one of the researchers will trans-
port the simulated patients to all the visits and thus will
validate the process and the storage of the data.
Characterization of the processes in the drugstores and
drugstores/pharmacies
A self-designed questionnaire will be constructed from the
requirements of Colombian pharmaceutical regulations and
different bibliographical references [36, 37] to characterize
the processes associated with the use the drugs with fisca-
lized substances, including compliance with the regulations,
and to determine the level of risk perception with of use of
these drugs in the pharmacy staff.
Implementation of the ambulatory (outpatient) pharmacy
services
A questionnaire will be constructed from the requirements
of Colombian pharmaceutical regulations and different bib-
liographical references [36, 37] for the measurement and
degree of implementation of ambulatory (outpatient) phar-
macy services.
Level of pharmacy staff satisfaction with the continuing
education program
A questionnaire will be constructed from different biblio-
graphical references [36, 38] to evaluate the satisfaction
level of pharmacy staff about the continuing education
program. A 5-point scale ranging from excellent, good,
satisfactory, needs improvement, and unacceptable will be
used in the questionnaire.
Level of satisfaction of patients or caregivers with the
ambulatory (outpatient) pharmacy services
A questionnaire will be constructed from the require-
ments of Colombian pharmaceutical regulations and dif-
ferent bibliographical references [39, 40] to evaluate the
information and education services on the appropriate
use of drugs. The questionnaire will inquire about the
following: (1) establishment information, (2) patient or
caregiver information, (3) medication information, (4)
assessment of the information and education service,
and (5) qualification of the care received. The satisfac-
tion of the care received in drugstores or drugstores/
pharmacies will be evaluated with a 5-point scale ran-
ging from excellent, very good, good, satisfactory, regu-
lar, and bad
To promote the retention of participants and complete
follow-ups, the pharmacy staff will receive a physical cer-
tificate when he/she completes each module of the virtual
course, which is part of the intervention (intervention
group). Additionally, at the end of the follow-up time, all
pharmacies of the intervention and control groups will re-
ceive a physical certificate that guarantees that said estab-
lishment participated in the study.
Data management
Only one of the researchers involved in the trial will have
access to the data entry. The data will be controlled by a
second investigator to avoid errors in transcription. The
data will be stored in a database. Those involved in this
study will be the only ones with access to the information.
We will back up the database every week in 2 different
computers to protect the information. All the question-
naires will be carried out in physical format, except the
questionnaire that evaluates the satisfaction of the con-
tinuing education program in the intervention group,
which will be sent by means of an electronic survey, and
the information will be stored online in Excel format.
Statistical methods
Baseline and demographic characteristics will be analyzed
descriptively. All primary and secondary outcomes will be
compared in pre-post analyses and between-group com-
parisons. Comparisons for categorical variables will be
conducted by using the chi-square test (or the Fisher exact
test when appropriate). For continuous variables, we will
use the independent sample t test (if the distribution is
not normal, we will use the Mann-Whitney U test). Stu-
dent’s t test will be used to compare means and odds ra-
tios (ORs), and 95% confidence intervals (CIs) will be
estimated as well. ORs will be used with the data reported
from the knowledge questionnaire, to establish the
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association between receiving or not receiving the inter-
vention and improving or not knowing. Spearman’s cor-
relation will be used to identify the association for test and
re-test reliability. Multivariable analyses will be performed
to explain the association of multiple variables with the
factors significantly related to the primary outcome (such
as the job profile of the pharmacy staff, and others that
will be considered as relevant variables). The McNemar
tests will be used to analyze the difference in scores of the
competency’s questionnaire of skills and attitudes and the
scores of the knowledge questionnaire. All statistical tests
will be computed using the Statistical Package for the So-
cial Sciences (version 23; SPSS, Chicago, IL, USA) with
significance defined as a p < 0.05.
Data monitoring
The Trial Steering Committee (TSC) will be formed up
of two researchers of trial, the general coordinator of the
Coordinating Center of the Trial (CCT), and the admin-
istrative staff of the sponsor. The Pharmaceutical Pro-
motion and Prevention research group will be the
Coordinating Center of the Trial (CCT). This group is
formed up of teachers, students, and graduates of
pharmaceutical chemistry from the Faculty of Pharma-
ceutical and Food Sciences of the University of Antio-
quia. It will be in charge of the academic management
and technical aspects of the study, also meeting spaces
between researchers and sponsors. The person in charge
of all aspects of the local organization, including the
identification of possible recruits and consent, will be in
charge of one of the members of the Pharmaceutical
Promotion and Prevention research group, who will not
be part of the study as a researcher.
The Data Monitoring Committee (DMC) will be the
Technical Research Committee of the Research and Ex-
tension Center of the University of Antioquia, which is
made up of teaching and administrative staff. The com-
mittee will perform the role of administrative manage-
ment; the approval, control, and monitoring of financial
resources; and the final compliance with the commit-
ments of the trial. This committee will oversee the trial
and request follow-up reports every 6 months, which
will be done by two pharmacists of the Pharmaceutical
Promotion and Prevention research group. A Stake-
holder and Public Involvement Group (SPIG) will not be
formed for this trial.
There are no planned interim analyses or “detention
rules” specific to the study. Relevant agencies will be in-
formed about the participation of pharmacy staff and
pharmacies during their entire participation in the trial.
We will adhere to international confidentiality and re-
search practices and recommendations to monitor,
audit, and administer the investigation. Due to the na-
ture of the study, it is not necessary to make plans to
collect, evaluate, report, and manage spontaneously re-
quested and reported adverse events and other un-
wanted effects of trial interventions or behaviors. The
periodic storage of the information in the database will
show reports of the evaluation instruments, which will
allow the monitoring of quality and data and generate
reports according to the needs. The researchers involved
in this study will be the only ones with access to the in-
formation. Every week, we will make a backup copy of
the database on two different computers to protect the
information.
Limitations and potential bias
This study will use the simulated patient methodology
as a tool to evaluate the skills and attitudes of customer
service provided by pharmacy staff. This methodology
has validity and reliability in pharmacy practice research
[41]. To guarantee the quality of information, the simu-
lated patients will receive training. Furthermore, a re-
searcher will accompany the simulated patients on all
visits to the drugstores and drugstores/pharmacies. The
same researcher will make sure that the simulated pa-
tients complete the questionnaire immediately after each
visit, thus controlling for common biases in this type of
study. One possible limitation of our study is that the
visits will not be recorded to minimize the possible
biases associated with the collected information, as has
been recommended by some systematic reviews [41].
Discussion
We have planned this randomized trial to evaluate the
effect of drugs with fiscalized substance (including con-
trolled drugs) dispensation, health education, and phar-
macovigilance continuing education programs in
drugstores or drugstores/pharmacies. The intervention
of this trial will be designed, developed, implemented,
and evaluated, as a continuing education strategy to pro-
mote competencies in the proper utilization of drugs
with fiscalized substances (including controlled drugs) in
pharmacy staff, and therefore, it will contribute to redu-
cing deficiencies in medical care. In Colombia, to our
knowledge, this is the first controlled trial designed to
assess pharmacy staff competencies.
Drugstores or drugstores/pharmacies play an essential
role in the improvement of pharmacotherapy and pa-
tient outcomes, promotion of the rational use of drugs,
and reduction of healthcare costs [42]. Besides, an em-
ployee eligible to work in an ambulatory (outpatient)
pharmacy in Colombia is required to have one of the fol-
lowing educational levels (professional, technological, or
technical). Besides, there are other empirical profiles
called Drug Retailer (who does not have an educational
level and is also called Drugstore Director). As a conse-
quence, there is a large proportion of drugstores or
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drugstores/pharmacies that are managed by pharmacy
staff who do not have the training and continuing educa-
tion support [22, 43]. Recently, a cross-sectional, epi-
demiological study in Medellín (Colombia) drugstores or
drugstores/pharmacies focused on the characterization
of the use of drugs with fiscalized substances (including
controlled drugs) and the pharmacy processes. Exactly
700 drugstores or drugstores/pharmacies were visited,
and an equal pharmacy staff was interviewed. The most
drugs with fiscalized substances dispensed without a
valid medical prescription were amitriptyline 91.4%
(640), tramadol 90% (630), and trazodone 60% (419).
Around 60% of pharmacy staff do not have a technical
or professional title, and their perception about the cor-
rect dispensing of drugs with fiscalized substances may
be inadequate. A high percentage of the pharmacy staff
perceives educational failures focused on the correct use
of drugs [22].
Additionally, a systematic review describes different
educational interventions with the support of ICTs and
the effects on pharmaceutical knowledge and skills
found. According to this review, they included 19 arti-
cles made mainly in developed countries. Most of the
studies included in the review focused on evaluating the
effect of continuing education programs on changing
pharmacists’ knowledge and skills, and only one study
evaluated the benefits of the program for patients or cli-
ents. The review authors conclude that there is insuffi-
cient evidence to support which methods from ICTs are
the most effective and that it is necessary to intervene
with robust, standardized, and validated methods [44].
A labor competence refers to a behavior that brings
together different elements, performance criteria, and
knowledge that determine the achievement, dominance,
or fulfillment of the competence in a real work environ-
ment, which can be measured and evaluated, based on
the combination of qualitative and quantitative research
techniques, such as the observation and use of measur-
ing instruments, respectively. Its measurement and
evaluation should always be carried out jointly consider-
ing the combination of knowledge (what do you know?),
skills (how do you do it?), and attitudes (how do you do
it?). In this context, the pharmacy staff needs to improve
their required competencies to contribute to the quality
of drug dispensation, health education, and pharmacov-
igilance, in order to minimize medication errors and to
help outpatients better manage their medicines. Con-
tinuing education, communication, and relationships
with other health professionals are crucial to improving
these competencies and, consequently, to achieve opti-
mal patient medication management.
Trial status
This study is currently in follow-up and intervention.
Protocol version: 0017102017MC. Registered on 28
November 2017.
Trial registration: NCT03388567.
Date of recruitment began on December 1, 2018.
Date of recruitment will be completed on December
31, 2019.
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